ArticleAmerican journal of preventive cardiology2026
Very low-grade albuminuria is linked to arterial stiffness in a population-based cohort.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Impact of Severe Albuminuria on the Proinflammatory Monocyte Subset CD14++CD16+ and Antigen-Specific Immune Responses.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Albuminuria even at low levels and increased arterial stiffness are associated with higher cardiovascular risk. Very low-grade albuminuria (VLGA; urinary albumin-creatinine ratio [uACR] <30 mg/g) has been linked to adverse outcomes, but its association with arterial stiffness in the general population, particularly among individuals without major cardiometabolic disease, remains uncertain. Methods: We analyzed data from 7613 participants of the German National Cohort (NAKO) with available uACR and brachial-ankle pulse wave velocity (PWV[ba]) measurements. Multivariable linear regression was used to assess the association between log₁₀-transformed uACR and PWV(ba), adjusting for age, sex, systolic blood pressure, obesity indices, LDL-cholesterol, HbA1c, and estimated glomerular filtration rate (eGFR). A low-risk subgroup excluded participants with arterial hypertension or diabetes mellitus. Results: Among included participants, 49.6 % were female and 7100 (93.3 %) had uACR <30 mg/g. In the full cohort, a 10-fold higher uACR was associated with higher PWV(ba) by 0.10 m/s (95 % CI 0.03-0.17). Similar associations were observed in the VLGA subgroup (0.16 m/s; 95 % CI 0.07-0.25). In the low-risk VLGA subgroup ( Conclusion: Higher uACR was consistently associated with greater arterial stiffness across the full cohort and among individuals with very low-grade albuminuria, including those without arterial hypertension or diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.